Communitites of Focus
Viridian is focused on engineering and developing potential best-in-class medicines for people living with autoimmune and rare diseases. More specifically, we are leveraging our expertise in antibody discovery and engineering to optimize monoclonal antibody therapies, with the aim of improving their safety and efficacy, and providing convenient ways of administering therapies.
Viridian is researching potential new therapies for autoimmune and rare diseases.
Thyroid Eye Disease
Thyroid eye disease, commonly referred to as TED, is an autoimmune condition characterized by inflammation, growth, and damage to tissues around and behind the eyes.